Zecotek Photonics Inc. (ZMSPF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerZecotek Photonics Inc. (ZMSPF) trades at $0.00001. Zecotek Photonics Inc. is a photonics technology company specializing in advanced imaging systems and 3D display technologies for various applications. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for ZMSPF: ZMSPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Zecotek Photonics Inc. (ZMSPF) Healthcare & Pipeline Overview
Zecotek Photonics Inc. leverages cutting-edge photonics technology to deliver innovative imaging systems and 3D display solutions, positioning itself as a key player in the healthcare and industrial sectors focused on research and commercial applications.
What Is the Investment Thesis for ZMSPF?
Zecotek Photonics Inc. presents a unique opportunity in the healthcare and photonics sectors, driven by its innovative product offerings and strategic focus on advanced imaging technologies. The company's diverse portfolio, including high-performance scintillation crystals and 3D display technologies, positions it well within a growing market. As the demand for enhanced imaging solutions in medical and industrial applications continues to rise, Zecotek's growth catalysts include expanding its market presence in China and increasing adoption of its 3D technologies. Despite current financial challenges, including a significant negative profit margin, the company's ongoing research initiatives and product development efforts could lead to substantial revenue growth in the coming years. Monitoring key performance indicators and market trends will be essential for assessing Zecotek's potential trajectory.
Based on FMP financials and quantitative analysis
ZMSPF Key Highlights
Market Cap: $0.00B indicates the company is currently not valued in the market.
- P/E Ratio: -0.00 reflects financial challenges, with no earnings reported.
- Profit Margin: -4063.0% signifies significant operational losses.
- Gross Margin: -225.5% suggests cost management issues.
- Beta: -6.44 indicates high volatility compared to the market.
Who Are ZMSPF's Competitors?
ZMSPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ALRTF ALR Technologies Inc. | $0.02 | 0.00% | $12.6M | — |
| ANPCY CelLBxHealth plc | $0.07 | 0.00% | $22.0M | — |
| EMOR Healixa Inc. | $0.04 | 0.00% | $30.7M | — |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $0.16 | 0.00% | $20.1M | — |
| BJDX Bluejay Diagnostics, Inc. | $0.84 | -1.12% | 30 5-pillar | |
| NVNO enVVeno Medical Corporation | $8.10 | +0.75% | $5.63M | 33 5-pillar |
| BDMD Baird Medical Investment Holdings Limited | $0.75 | +0.91% | $31.7M | — |
| SNWV SANUWAVE Health, Inc. | $4.82 | +4.33% | $41.5M | 36 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ZMSPF's Key Strengths?
Innovative product portfolio in photonics technology.
- Strong research and development capabilities.
- Established presence in the healthcare and industrial sectors.
- Diverse range of applications across multiple industries.
What Are ZMSPF's Weaknesses?
Significant operational losses reflected in financial metrics.
- Limited market capitalization and liquidity.
- Dependence on the success of new product launches.
- Challenges in scaling operations effectively.
What Are the Key Risks for ZMSPF?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory challenges that could impact product approvals and market entry.
- Financial instability due to significant operational losses.
- Intense competition from established players in the medical devices sector.
- Market volatility affecting investor sentiment and stock performance.
What Threats Does ZMSPF Face?
- Intense competition from established players in the medical devices sector.
- Regulatory challenges in the healthcare industry.
- Market volatility affecting investor confidence.
- Technological advancements by competitors potentially outpacing Zecotek.
What Are ZMSPF's Competitive Advantages?
- Innovative product offerings that differentiate Zecotek from competitors.
- Strong focus on research and development to stay ahead in technology.
- Established relationships with key players in the healthcare and industrial sectors.
- Specialization in niche markets such as high-energy physics and advanced imaging.
What Does ZMSPF Do?
Zecotek Photonics Inc., founded in 1983 and headquartered in Richmond, Canada, is a leading photonics technology company dedicated to developing advanced imaging systems and related technologies. Originally established as Zecotek Medical Systems Inc., the company rebranded in November 2007 to reflect its broader focus on photonics applications beyond medical systems. Zecotek operates through three main divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. The company specializes in a diverse range of products, including lutetium fine silicate scintillation crystals, solid-state micro-pixel avalanche photo diode photo detectors, and integrated detector modules. In addition to imaging systems, Zecotek is pioneering the development of glasses-free 3D displays, 3D auto-stereoscopic displays, and 3D printers, catering to various sectors such as medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering, and multimedia markets. With a strong emphasis on research and innovation, Zecotek aims to enhance the capabilities of imaging technologies, thereby improving outcomes in both commercial and research applications.
What Products and Services Does ZMSPF Offer?
- Develop advanced imaging systems for medical and industrial applications.
- Create high-performance scintillation crystals for medical imaging.
- Innovate glasses-free 3D display technologies for various sectors.
- Provide solid-state micro-pixel avalanche photo diode photo detectors.
- Manufacture integrated detector modules for enhanced imaging capabilities.
- Engage in research and development to advance photonics technology.
How Does ZMSPF Make Money?
- Generate revenue through the sale of advanced imaging systems and components.
- Collaborate with research institutions and pharmaceutical companies for product development.
- License technology for use in various commercial applications.
- Engage in government and private sector contracts for specialized projects.
What Industry Does ZMSPF Operate In?
The medical devices industry is experiencing robust growth, driven by technological advancements and increasing demand for innovative healthcare solutions. Zecotek Photonics Inc. is strategically positioned within this growing landscape, focusing on photonics technology that enhances imaging capabilities in medical and industrial applications. The competitive landscape includes companies like ALRTF, ANPCY, BTCY, EMOR, and IMUC, which are also innovating in the medical devices space, emphasizing the importance of differentiation through advanced technology and product offerings.
Who Are ZMSPF's Key Customers?
- Healthcare providers and hospitals seeking advanced imaging solutions.
- Pharmaceutical companies requiring imaging technology for research.
- Industrial clients in need of photonics technology for material processing.
- Research institutions focusing on high-energy physics and medical applications.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Zecotek Photonics Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Richmond, CA. The company is led by CEO Jiang Chen. ZMSPF has traded publicly since 2009.
Key Financial Metrics
Return on equity for Zecotek Photonics Inc. stands at 82.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.17 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Zecotek Photonics Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Forward Outlook
Wall Street analysts project Zecotek Photonics Inc. revenue of about $8.7M for fiscal 2026, with EPS near $0.02.
ZMSPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
ZMSPF Latest News
No recent news available for ZMSPF.
ZMSPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ZMSPF.
Price Targets
Wall Street price target analysis for ZMSPF.
ZMSPF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ZMSPF; grades run from A+ (80-100) to F (below 30).
Leadership: Jiang Chen
CEO
Jiang Chen has extensive experience in the photonics and technology sectors, having led Zecotek Photonics Inc. since its rebranding in 2007. He holds advanced degrees in engineering and business, bringing a strong technical and managerial background to the company. Prior to joining Zecotek, Jiang held various leadership positions in technology firms, focusing on product development and market expansion.
Track Record: Under Jiang's leadership, Zecotek has expanded its product offerings significantly, particularly in the areas of imaging systems and 3D display technologies. His strategic vision has guided the company through key partnerships and research initiatives, enhancing its competitive positioning in the photonics industry.
ZMSPF OTC Market Information
The OTC Other tier includes companies that do not meet the requirements for higher tiers like OTCQX or OTCQB. These companies may have limited financial disclosure and lower trading volumes compared to those on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure may hinder investor confidence.
- Low trading volume could lead to price volatility.
- Potential regulatory scrutiny due to OTC trading status.
- Increased risk of fraud or manipulation in less regulated markets.
- Verify the company's financial health through available reports.
- Assess the management team's experience and track record.
- Research the competitive landscape and market position.
- Evaluate the company's product pipeline and innovation strategy.
- Check for any legal or regulatory issues affecting the company.
- Established history since 1983 in the photonics industry.
- Active engagement in research and development.
- Partnerships with recognized institutions in healthcare and technology.
Common Questions About ZMSPF (Healthcare)
What do analysts say about ZMSPF stock?
Analysts have mixed views on Zecotek Photonics Inc. due to its current financial challenges, including significant operational losses. However, they recognize the company's innovative product offerings and potential growth in the healthcare and industrial markets as key considerations for future performance. Valuation metrics remain uncertain given the lack of earnings.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial disclosure status is currently unknown, which may limit transparency.